Article
AbbVie's Tax Triumph: Breaking Free From Capital Loss Limitations
The U.S. Tax Court recently issued an opinion in AbbVie Inc. v. Commissioner, Docket No. 2597-23, allowing the approximately $1.6 billion "Break Fee" paid by AbbVie to be treated as an ordinary and necessary business expense under...
Holland & Knight